|
|
|
|
|
|
|
NovaBay Pharmaceuticals- Inc. (NBY)
|
|
2.6 0 (0%)
|
06-15 16:00
|
|
Open:
|
2.51
|
Pre. Close:
|
2.6
|
|
High:
|
2.6252
|
Low:
|
2.51
|
|
Volume:
|
4,484
|
Market Cap:
|
44M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
2.632 - 2.651
|
2.651 - 2.665
|
|
Low:
|
2.476 - 2.495
|
2.495 - 2.51
|
|
Close:
|
2.574 - 2.605
|
2.605 - 2.628
|
|
|
|
Technical analysis (as of: 2018-06-15 4:27:56 PM)
|
|
Overall:
|
|
|
Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.
|
|
Target:
|
Six months: 3.60 One year: 4.38
|
|
Support:
|
Support1: 2.00 Support2: 1.66
|
|
Resistance:
|
Resistance1:
3.08 Resistance2: 3.75
|
|
Pivot:
|
2.46 
|
|
Moving Averages:
|
MA(5): 2.61  MA(20): 2.53
MA(100): 3.18 MA(250): 3.76
|
|
MACD:
|
MACD(12,26):
-0.10 Signal(12,26,9): -0.15
|
|
%K %D:
|
%K(14,3): 34.29 %D(3): 34.03
|
|
RSI:
|
RSI(14): 47.88
|
|
52-Week:
|
High: 5
Low: 2 Change(%): -7.1
|
|
Average Vol(K):
|
3-Month: 1102
10-Days 3652
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.NBY has closed below upper band by 31.3%. Bollinger Bands are 26% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-05-11T23:03:12-04:00
NovaBay Pharmaceuticals' (NBY) CEO Mark Sieczkarek on Q1 2018 Results - Earnings Call Transcript
2018-05-10T16:23:03-04:00
NovaBay misses by $0.06, misses on revenue
2018-05-10T16:05:00-04:00
NovaBay Pharmaceuticals Reports First Quarter 2018 Financial Results
2018-05-07T06:50:00-04:00
NovaBay Pharmaceuticals to Hold First Quarter 2018 Conference Call on May 10, 2018
2018-03-20T22:54:06-04:00
NovaBay Pharmaceuticals' (NBY) CEO Mark Sieczkarek on Q4 2017 Results - Earnings Call Transcript
2018-03-20T16:11:54-04:00
NovaBay beats by $0.09, beats on revenue
2018-03-20T16:05:00-04:00
NovaBay Pharmaceuticals Reports 2017 Fourth Quarter and Full Year Financial Results
2018-02-21T06:50:00-05:00
NovaBay Pharmaceuticals to Hold 2017 Fourth Quarter and Full Year Conference Call on March 20, 2018
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
